FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: PROT

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

Proteonomix (PROT.OB) a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on the Company's addition to its Board of Directors. Proteonomix, Inc. is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors.

The China Fund, Inc.(NYSE:CHN) confirmed the amount of distributions of $2.2742 per share. The capital gain portion of the distributions is comprised of long-term capital gains at $1.8996 per share. The net investment income portion of the distribution is $0.3746 per share.

Proteonomix, Inc. (PROT.OB) is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors. Dr. McNiece, has served as Vice-President for Scientific Development and Chief Scientific Officer since November 11, 2009.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

___

Proteonomix, Inc. (PROT.OB)

PROT announced that it has filed a utility patent application for the Preparation and Use of Stromal Cells for Treatment of Cardiac Diseases.

Pages

ADVERTISE WITH US